ACC 21: The CONNECT-HF Trial

La SEC te lleva a ACC21 [IN] ∙ The CONNECT-HF TrialПодробнее

La SEC te lleva a ACC21 [IN] ∙ REHAB-HF TrialПодробнее

ACC Cardiology Hour From ACC.21 With Dr. Valentin FusterПодробнее

HF, ACS, and Imaging Perspectives on ACC.21 Hot TrialsПодробнее

Dr. Drachman Provides Overview of ACC.21 Late-Breaking Clinical ResearchПодробнее

Day 1 Highlights | ACC.21Подробнее

ACC 21: Findings From the HOST-EXAM TrialПодробнее

ACC 24 Late-Breaker Discussion: The RELIEVE-HF TrialПодробнее

ACC 21: Findings from the RAFT-AF TrialПодробнее

Day 2 Highlights | ACC.21Подробнее

Dr. Lanfear Gives a Look at the ACC.21 Heart Failure & Cardiomyopathies PathwayПодробнее

ACC 2021 Discussion: The LIFE TrialПодробнее

ACC 21 HighlightsПодробнее

ACC 23 Late-Breaker Discussion: The BETTER-CARE HF TrialПодробнее

ACC 22: Results from the EMPULSE Study - Empagliflozin Proves Beneficial for Patients with HFПодробнее

ACC.24: The STEP HFpEF DM TrialПодробнее

ESC HF 21 Discussion: The VICTORIA TrialПодробнее

ESC TV at #AHA21 - Expert Perspectives on the CHIEF-HF TrialПодробнее